Charles River Laboratories Q4 Review: Approaching A Bottom

Shares of Charles River Laboratories International, Inc. ( CRL ) have been a mixed performer over the past year, trading essentially flat. That said, it has been a rollercoaster ride for investors, as shares have been negatively impacted by fears around FDA efforts to phaseOver fifteen years of experience making contrarian bets based on my macro view and stock-specific turnaround stories to garner outsized returns with a favorable risk/reward profile. If you want me to cover a specific stock or have a quest ...